Global University Venturing

A range of strategic investors have backed a series A5 round for the clean nuclear energy technology developer that leverages OSU research.

Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

New and returning investors have chipped into the ETH Zurich plant-based meat spinout’s pre-series B round, five months after it completed a series A.

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

The industrial sensor manufacturer spun out of Michigan and Virginia has increased its latest round to $51m in a tranche backed by 3M, Ericsson and Armstrong International.

The MSU Foundation-run Pre-Seed III Fund has secured an additional $6.5m from MEDC, more than a year after the vehicle was formed with $3m.

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.